top of page

WAVEGATE NEWS

Public·1 member

WAVEGATE CORPORATION | NEWS

 

May 4, 2026

 

Statement Regarding the December 2024 Series A Funding Announcement

 

In December 2024, Wavegate Corporation announced a $26 million Series A funding round with UCEA Capital Partners Ltd. as lead investor. The financing arrangement was not completed, and the round did not close.

 

We recognize that coverage of the original announcement continues to be available through third-party media outlets. This statement is provided to ensure that the public record accurately reflects the current status of Wavegate's financing, and to reaffirm that Wavegate's commitments to its partners and investors are always guided by transparency and integrity.

 

Wavegate is actively engaged in fundraising, with a strong and ongoing pipeline of conversations with qualified investors. Our commitment to bringing the Ellipse™ platform to patients living with chronic pain is stronger than ever.

 

For investor inquiries, please contact: info@wavegate.us


23 Views
  • LinkedIn
  • X
  • Instagram
  • Grey Facebook Icon

DISCLAIMER

Wavegate's EllipseTM platform with Active LoopTM technology has not yet been evaluated by the U.S. Food and Drug Administration and is not currently available for sale in the United States.

© 2026 by WAVEGATE CORPORATION

Ellipse, StimuLux, and Active Loop are trademarks of Wavegate Corporation

Ellipse platform technology is covered by multiple US and International issued patents and patents pending.

bottom of page